Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
January 28, 2022
Providing patients with high-quality essential medicines requires a well-functioning procurement, distribution, and regulatory system. However, in many low- and lower-middle-income countries (LMICs), public sector supply chain performance is far from optimal, resulting in frequent stockouts at healt...
Jan
28
2022
11:00—12:15 PM Eastern Time (US and Canada)
January 24, 2022
Providing patients with high-quality essential medicines requires a well-functioning procurement, distribution, and regulatory system. However, in many low- and lower-middle-income countries (LMICs), the centrally run supply chain is unable to provide health facilities with uninterrupted supply lead...
Blog Post
December 09, 2021
Antibiotic resistance (AMR) is not a new problem. However, the global community has been slow to implement recommended policy measures and achieve systemic change. CGD will launch a working group on antimicrobial resistance—seeking to improve antibiotic access and R&D in low- and middle-inc...
Dec
15
2021
9:00—10:15 AM Eastern Time
December 06, 2021
There have been several explorations and a few impactful uses of Machine Learning (ML) and advanced analytics during the COVID-19 pandemic. A lot of the discussion around the use of ML has centered around their use for case projections, accelerating the development of vaccines and treatments, and ne...
Nov
30
2021
9:00—10:15 AM Eastern Time (US and Canada)
November 17, 2021
Ineffective and inefficient registration processes impede access to lifesaving, quality-assured essential medicines. As a result of inadequate legal provisions, limited capacity within National Regulatory Authorities, and long and unpredictable registration processes as well as low profit margins an...
Blog Post
October 21, 2021
Poor understanding about vaccine capacity was one of the reasons why the world did not have the infrastructure needed to manufacture sufficient doses. This blogs proposes three actions to start tracking manufacturing capacity better and create robust estimates for the world’s vac...